A multicenter, randomized controlled study of the clinical efficacy of intravenous peramivir versus oseltamivir against influenza A and B virus infection in high-risk patients

Trial Profile

A multicenter, randomized controlled study of the clinical efficacy of intravenous peramivir versus oseltamivir against influenza A and B virus infection in high-risk patients

Completed
Phase of Trial: Phase II

Latest Information Update: 16 May 2016

At a glance

  • Drugs Peramivir (Primary) ; Oseltamivir
  • Indications Influenza A virus infections; Influenza B virus infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Sep 2015 Primary endpoint has not been met. (Duration of symptoms), according to an abstract presented at the Joint 55th Interscience Conference on Antimicrobial Agents and Chemotherapy and 28th International Congress of Chemotherapy
    • 21 Sep 2015 Results presented at the Joint 55th Interscience Conference on Antimicrobial Agents and Chemotherapy and 28th International Congress of Chemotherapy
    • 04 Jun 2014 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top